why choose us

300×250 Ad Slot

Research Article: Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma

Date Published: 2025-04-16

Abstract:
Background: Disulfidptosis is an emerging type of programmed cell death related to ROS accumulation and aberrant disulfide bond formation. Multiple myeloma (MM) is the second most prevalent hematologic malignancy characterized by a high synthesis rate of disulfide bond-rich proteins and chronic oxidative stress. However, the relationship between disulfidptosis and MM is still unclear.

No summary available.

300×250 Ad Slot